S. Cavalcanti

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
S. M. T. Cavalcanti, Suellen Melo Tiburcio Cavalcanti, Suellen M. t. Cavalcanti, Suellen M. T. Cavalcanti, Suellen Melo T Cavalcanti, S.m.t. Cavalcanti, Suellen M T Cavalcanti, Suellen Melo Tibúrcio Cavalcanti
Publication record
9 papers · 718 citations · H-index 7

PAPERS

Multiple Lipid Nanoparticles (MLN), a New Generation of Lipid Nanoparticles for Drug Delivery Systems: Lamivudine-MLN Experimental Design
201724 citationsauthor #1
Design, synthesis and structure-activity relationship of phthalimides endowed with dual antiproliferative and immunomodulatory activities.
201539 citationsauthor #4
Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives.
201527 citationsauthor #4
Novel phthalimide derivatives with TNF-α and IL-1β expression inhibitory and apoptotic inducing properties
201413 citationsauthor #5
Outstanding effect of the conformational restriction of isoquinolines: hints for the development of optimized antimicrobial agents
20137 citationsauthor #7
Identification of N-acylhydrazones as potent TNF inhibitors
20130 citationsauthor #5
Discovery of Phthalimides as Immunomodulatory and Antitumor Drug Prototypes
201029 citationsauthor #5
Inside Cover: Discovery of Phthalimides as Immunomodulatory and Antitumor Drug Prototypes (ChemMedChem 4/2010)
20101 citationsauthor #5
Halogen atoms in the modern medicinal chemistry: hints for the drug design.
2010581 citationsauthor #2

TIMELINE

2010 611 citations

2013 7 citations

2014 13 citations

2015 66 citations

2017 24 citations

COAUTHOR MAP

CONCEPT FOOTPRINT